As of April 18, 2025, Jardine Matheson (J36.SI) has a market cap of $10.43 billion USD. According to our data, Jardine Matheson is ranked No.1555 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 18, 2025 | $10.43 B |
-0.11%
|
Dec 30, 2024 | $10.44 B |
5.54%
|
Dec 28, 2023 | $9.89 B |
-15.18%
|
Dec 29, 2022 | $11.66 B |
-3.73%
|
Dec 30, 2021 | $12.11 B |
0.78%
|
Dec 30, 2020 | $12.02 B |
4.65%
|
Dec 30, 2019 | $11.49 B |
-17.86%
|
Dec 30, 2018 | $13.99 B |
19.86%
|
Dec 28, 2017 | $11.67 B |
12.54%
|
Dec 29, 2016 | $10.37 B |
16.40%
|
Dec 30, 2015 | $8.91 B |
-18.08%
|
Dec 30, 2014 | $10.87 B |
19.30%
|
Dec 30, 2013 | $9.11 B |
-13.71%
|
Dec 30, 2012 | $10.56 B |
34.98%
|
Dec 29, 2011 | $7.82 B |
8.17%
|
Dec 30, 2010 | $7.23 B |
52.89%
|
Dec 29, 2009 | $4.73 B |
69.70%
|
Dec 30, 2008 | $2.79 B |
-31.58%
|
Dec 30, 2007 | $4.07 B |
33.03%
|
Dec 28, 2006 | $3.06 B |
27.58%
|
Dec 29, 2005 | $2.40 B |
10.68%
|
Dec 30, 2004 | $2.17 B |
80.10%
|
Dec 30, 2003 | $1.20 B |
53.07%
|
Dec 30, 2002 | $0.79 B |
10.97%
|
Dec 30, 2001 | $0.71 B |
0.88%
|
Dec 28, 2000 | $0.70 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Johnson & Johnson
JNJ
|
$379.48 B |
-0.003 M
|
![]() USA
|
![]() Pfizer
PFE
|
$125.57 B |
0.001 M
|
![]() USA
|
![]() Merck
MRK
|
$196.28 B |
0.008 M
|
![]() USA
|
![]() AbbVie
ABBV
|
$306.02 B |
0.008 M
|
![]() USA
|
![]() Bristol-Myers Squibb
BMY
|
$100.17 B |
-0.004 M
|
![]() USA
|
![]() Amgen
AMGN
|
$149.09 B |
0.124 B
|
![]() USA
|
![]() Gilead Sciences
GILD
|
$130.32 B |
-0.001 M
|
![]() USA
|
![]() Eli Lilly
LLY
|
$754.27 B |
0.008 M
|
![]() USA
|
![]() Novartis
NVS
|
$219.89 B |
0.932 B
|
![]() Switzerland
|
![]() GlaxoSmithKline
GSK
|
$72.79 B |
-0.000 M
|
![]() UK
|
![]() Sanofi
SNY
|
$124.64 B |
0.327 B
|
![]() France
|
![]() AstraZeneca
AZN
|
$210.29 B |
0.735 B
|
![]() UK
|
![]() Biogen
BIIB
|
$17.36 B |
-0.001 M
|
![]() USA
|
Market Cap | = | J36.SI Stock Price | * | J36.SI Shares Outstanding |
= | $41.06 | * | 0.25 B | |
= | $10.43 B |